Table 2. Allele frequencies of the CAV1–CAV2 variants among NTG patients and controls.

SNP	Alleles (1/2)	Total				Males				Females
		MAF		P-value	OR (95%CI)	MAF		P-value	OR (95%CI)	MAF		P-value	OR (95%CI)
		Cases (n=292)	Controls (n=352)			Cases (n=140)	Controls (n=193)			Cases (n=152)	Controls (n=159)
rs1052990	T/G	0.179	0.236	0.014	0.71 (0.54–0.93)	0.192	0.223	0.331	0.83 (0.56–1.21)	0.168	0.250	0.012	0.60 (0.41–0.90)
rs4236601	G/A	0.000	0.000	—	—
rs7795356	C/T	0.052	0.058	0.592	0.88 (0.54–1.42)	0.040	0.052	0.461	0.75 (0.36–1.60)	0.063	0.066	0.841	0.94 (0.49–1.78)

1, major allele; 2, minor allele; CI, confidence interval; MAF, minor allele frequency; OR, odds ratio; SNP, single-nucleotide polymorphism.

P-values were calculated using a χ²-test 2 × 2 contingency table.